GOLDEN, Colo. — November 5, 2024 — PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free technology, today announced their upcoming poster presentation on November 8, 2024 at the Society of Immunotherapy of Cancer (SITC) conference. The poster (#741), entitled Modulating Immune
View GOLDEN, Colo. — October 24, 2024 — PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free technology, today announced the results of an implementation study in Nigeria that evaluated the impact on coverage, costs, and acceptability of intradermal fractional inactivated poliovirus vaccine
View GOLDEN, Colo. — June 27, 2024 — PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its innovative delivery systems, today announced that their Tropis® Intradermal (ID) Needle-free System will be used in a house-to-house polio immunization campaign. With an aim of significantly reducing the
View GOLDEN, Colo. — April 24, 2024 — PharmaJet®, a company that strives to improve the performance and outcomes of medicines with its innovative delivery systems, today announced the Nature publication of Gennova Biopharmaceutical’s Phase 2/3 clinical trial conducted to evaluate the safety and immunogenicity of its novel samRNA-based Covid-19 vaccine
View GOLDEN, Colo. — October 24, 2023 — PharmaJet® , a company that engineers precision delivery systems that overcome the challenges of vaccines and pharmaceuticals delivery, today announced the implementation of a study in Nigeria to evaluate the impact of intradermal vaccine administration of fractional inactivated poliovirus vaccine (fIPV) using their
View GOLDEN, Colo. — June 28, 2023 – PharmaJet®, a company engineering precision delivery systems that overcome challenges of nucleic acid vaccine delivery, today announced that its Tropis® System is now the exclusive intradermal delivery system for two authorized novel Covid-19 vaccines:
View GOLDEN, Colo. — May 23, 2023 — PharmaJet®, a company engineering precision delivery systems that overcome the challenges of vaccine delivery, today announced their support for the World Health Organization’s (WHO) polio eradication campaigns in Pakistan starting in May 2023. PharmaJet is providing an additional 5 million syringes to the
View GOLDEN, Colo. — April 18, 2023 —PharmaJet®, a company engineering Precision Delivery Systems™ (PDS) that overcome the challenges of vaccine delivery, today announced that it received a scope expansion and 3-year extension of its multi-year agreement with the Joint Science and Technology Office of the U.S. Defense Threat Reduction Agency
View GOLDEN, Colo. — April 4, 2023 — Results of a comprehensive review of published scientific literature comparing data associated with various DNA vaccine delivery methods will be presented at the World Vaccine Congress 2023 on April 5, 2023 at 5:10 pm ET.
View Load more